| |
Non-PMI patients (n = 1122)
|
PMI patients (n = 59)
|
P
|
|---|
|
Age (years)
|
54 (48–60)
|
57 (51–63)
|
0.01
|
|
Male
|
959 (85.47%)
|
45 (76.27%)
|
0.05
|
|
BMI (kg/m2)
|
27.8 (24.8–30.9)
|
28.2 (24.2–33.2)
|
0.62
|
|
BSA (m2)
|
1.9 (1.8–2)
|
1.9 (1.8–2)
|
0.22
|
|
NYHA III-IV
|
326 (29.06%)
|
28 (47.46%)
|
0.01
|
|
CCS III-IV
|
463 (41.27%)
|
32 (54.24%)
|
0.049
|
|
Congestive heart failure
|
17 (1.52%)
|
5 (8.47%)
|
˂ 0.001
|
|
Previous myocardial infarction
|
334 (29.93%)
|
19 (32.79%)
|
0.65
|
|
Thrombolysis within 24 h
|
9 (0.81%)
|
2 (3.51%)
|
0.1
|
|
Previous PCI
|
112 (10.02%)
|
5 (8.77%)
|
0.76
|
|
Diabetes mellitus
|
461 (41.35%)
|
31 (52.54%)
|
0.09
|
|
Hypertension
|
606 (54.25%)
|
40 (67.80%)
|
0.04
|
|
Severe renal impairment/dialysis
|
26 (2.33%)
|
3 (5.08%)
|
0.18
|
|
COPD
|
24 (2.15%)
|
3 (5.08%)
|
0.15
|
|
Cerebrovascular disease
|
27 (2.42%)
|
1 (1.69%)
|
˃0.99
|
|
Peripheral vascular disease
|
13 (1.17%)
|
2 (3.45%)
|
0.17
|
|
Atrial fibrillation
|
4 (0.37%)
|
0
|
˃0.99
|
|
Hemoglobin (mg/dl)
|
13.5 (12.4–14.3)
|
13.2 (12.4–14.2)
|
0.75
|
|
Creatinine (mg/dl)
|
1 (0.9–1.2)
|
1 (0.9–1.3)
|
0.55
|
|
Bilirubin (mg/dl)
|
0.6 (0.5–0.8)
|
0.6 (0.4–0.8)
|
0.26
|
|
Ejection fraction
| | |
0.11
|
|
Good
|
846 (77.54%)
|
39 (67.24%)
| |
|
Fair
|
234 (21.45%)
|
18 (31.03%)
| |
|
Poor
|
11 (1.01%)
|
1 (1.72%)
| |
- Continuous variables were presented as mean and standard deviation if normally distributed and median (25th–75th percentiles) if not normally distributed. Categorical data were presented as frequencies and percentages
- BMI body mass index, BSA body surface area, CCS Canadian Cardiovascular Society, COPD chronic obstructive pulmonary disease, NYHA New York Heart Association, PCI percutaneous coronary interventions, PMI perioperative myocardial infarction
